Walker James, Won Daniel, Guo James, Rana Jamal S, Allen Norrina B, Ning Hongyan, Lloyd-Jones Donald M
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Kaiser Permanente Oakland Medical Center, Oakland, California.
JAMA Cardiol. 2025 Apr 23. doi: 10.1001/jamacardio.2025.0630.
Most literature on the association between cardiovascular health (CVH) and incident cardiovascular disease (CVD) and mortality has relied on single midlife measurements. Understanding how cumulative CVH over time influences later-life CVD and mortality may aid early prevention.
To determine whether cumulative CVH, as measured by the American Heart Association Life's Essential 8 (LE8) from age 18 to 45 years, is associated with incident CVD and mortality in midlife.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study, the Coronary Artery Risk Development in Young Adults (CARDIA) study, collected CVH data for participants from 4 US centers from 1985 to 2020. Multivariate Cox proportional hazard models assessed the associations of (1) cumulative LE8 score by quartile, (2) cumulative LE8 score and score at age 45 years, and (3) cumulative LE8 score and LE8 score slope from age 18 to 45 years with incident CVD and mortality after age 45 years.
Incident CVD and all-cause mortality. Cumulative LE8 score was calculated as the area under the curve of the LE8 score (0-100, higher is better CVH) over time from age 18 to 45 years.
There were 4832 CARDIA participants (2690 [55.7%] female and 2142 [44.3%] male) with a mean (SD) cumulative LE8 score from age 18 to 45 years of 2018.8 (95.0) point × years. Compared with quartile 1 (Q1, ie, lowest CVH), Q2, Q3, and Q4 had significantly lower hazards for CVD (Q2 HR, 0.44; 95% CI, 0.32-0.61; Q3 HR, 0.26; 95% CI, 0.18-0.38; Q4 HR, 0.12; 95% CI, 0.07-0.21) and mortality (Q2 HR, 0.51; 95% CI, 0.36-0.71; Q3 HR, 0.38; 95% CI, 0.26-0.55; Q4 HR, 0.29; 95% CI, 0.18-0.45) after age 45 years. When cumulative LE8 score from age 18 to 45 years and LE8 score at age 45 years were in the model together, both were significantly associated with lower risk for CVD. Likewise, both cumulative LE8 score and positive slope of (improving) LE8 score from age 18 to 45 years were significantly associated with lower hazards for incident CVD after age 45 years.
Greater cumulative CVH and improvement in CVH during young adulthood, as well as better CVH in middle age, were all independently associated with lower risk for incident CVD in midlife. These results emphasize the importance of maintaining and improving CVH throughout young adulthood.
大多数关于心血管健康(CVH)与心血管疾病(CVD)及死亡率之间关联的文献都依赖于单一的中年时期测量数据。了解随时间累积的CVH如何影响晚年的CVD和死亡率可能有助于早期预防。
确定以美国心脏协会生命基本8项指标(LE8)从18岁至45岁所测量的累积CVH是否与中年时期发生的CVD及死亡率相关。
设计、背景和参与者:这项队列研究,即青年成人冠状动脉风险发展(CARDIA)研究,于1985年至2020年从美国4个中心收集了参与者的CVH数据。多变量Cox比例风险模型评估了以下因素与45岁之后发生的CVD及死亡率之间的关联:(1)按四分位数划分的累积LE8评分;(2)18岁至45岁的累积LE8评分及45岁时的评分;(3)18岁至45岁的累积LE8评分及LE8评分斜率。
发生的CVD及全因死亡率。累积LE8评分计算为18岁至45岁期间LE8评分(0 - 100分,分数越高CVH越好)随时间变化的曲线下面积。
共有4832名CARDIA参与者(2690名[55.7%]女性和2142名[44.3%]男性),18岁至45岁期间的平均(标准差)累积LE8评分为2018.8(95.0)分×年。与四分位数1(Q1,即CVH最低)相比,四分位数2(Q2)、Q3和Q4在45岁之后发生CVD的风险(Q2风险比[HR],0.44;95%置信区间[CI],0.32 - 0.61;Q3 HR,0.26;95% CI,0.18 - 0.38;Q4 HR,0.12;95% CI,0.07 - 0.21)和死亡率(Q2 HR,0.51;95% CI,0.36 - 0.71;Q3 HR,0.38;95% CI,0.26 - 0.55;Q4 HR,0.29;95% CI,0.18 - 0.45)显著更低。当18岁至45岁期间的累积LE8评分和45岁时的LE8评分同时纳入模型时,两者均与较低的CVD风险显著相关。同样,18岁至45岁期间的累积LE8评分以及(改善的)LE8评分的正斜率均与45岁之后发生CVD的较低风险显著相关。
青年期累积的CVH更高、CVH改善以及中年时更好的CVH均与中年时期发生CVD的较低风险独立相关。这些结果强调了在整个青年期维持和改善CVH的重要性。